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Background: Drug-eluting stents (DES) have an inhibitory effect on coronary collateral growth. Furthermore, this adverse effect may be enhanced 
by angiotensin II receptor blocker (ARB), suppressing angiogenic cytokines, and chemotactic proteins and growth factors.This prospective, 
randomized study was conducted to evaluate the effects of ARB on coronary collateral function after DES implantation in hypertensive patients, 
compared to a calcium channel blocker (CCB).
Methods: Forty-three hypertensive patients with coronary artery stenosis treated with sirolimus-eluting stents were randomly assigned to either 
ARB (Termisartan) or CCB (Amlodipine) treatment group (ARB: n=20, CCB: n=23). Coronary collateral function was assessed by simultaneous arotic 
and coronary wedge pressure during vascular balloon occlusion. Collateral flow index (CFI) is calculated by dividing mean distal coronary occlusive 
pressure by mean aortic pressure. Differences of CFI before and 3 months after procedure (ΔCFI) were evaluated for each stented vessel.
Results: CFI before procedure were similar between the groups (ARB vs. CCB; 0.16±0.07 vs. 0.16±0.06). Although CFI 3 months after procedure 
were significantly decreased compared to those of before procedure(0.10±0.09 vs. 0.16±0.06; p<0.001), ΔCFI were similar in both groups(ARB vs. 
CCB; -0.60±0.07 vs. -0.05±0.08; p=0.7, see figure).
Conclusions: ARB would not have adverse effects on coronary collateral function after DES implantation, compared to CCB. 
